Unser TeamWir sind für Sie da

Chefarzt

Prof. Dr. Thorsten Dill

Prof. Dr. med.Thorsten Dill

  • Innere Medizin
  • Kardiologie
  • Kardiovaskuläre MRT
  • EMAH (Erwachsene mit angeborenen Herzfehlern)
  • Leiter Ausbildungsstätte Interventionelle Kardiologie
  • Leiter HFU-Schwerpunktklinik

Tel.: 0211 2800-1221
thorsten.dill@sana.de

Curriculum Vitae Prof. Dr. med. Thorsten Dill

Prof. Dr. Thorsten Dill wurde in Hamburg geboren. Er studierte Medizin  an der Universität Hamburg und der Freien Universität Berlin. Von 1994 bis 1999 war er in der Medizinischen Klink des Universitätskrankenhauses Eppendorf in Hamburg tätig. Das Angebot an eines der größten Herzzentren in Deutschland zu gehen, nahm er 1999 an und wechselte an die Kerckhoff-Klinik GmbH in Bad Nauheim.  Er absolvierte die Prüfungen zum Internisten 2001 und Kardiologen 2003 und habilitierte an der Universität Giessen 2006.  Er leitete über zehn Jahre eine wissenschaftliche Arbeitsgruppe zur Kardialen Bildgebung und gilt für diesen Bereich, ebenso wie für die Behandlung des akuten Myokardinfarktes als national und international anerkannter Spezialist. Er ist Mitglied in nationalen und internationalen Steering Committees und Gutachter diverser Journals. Er ist Fellow of the European Society of Cardiology (FESC) und Mitglied des wissenschaftlichen Beirates der Deutschen Herzstiftung. Nach langjähriger Tätigkeit als Oberarzt und geschäftsführender Oberarzt wechselte er 2010 als Chefarzt der Medizinischen Klinik an das Sana-Krankenhaus Benrath.

Publikationsverzeichnis Prof. Dr. med. Thorsten Dill

Schriftenverzeichnis  (Original- und Übersichtsarbeiten)

  1. Barth S, Marwan M, Hausleiter J, Moshage W, Korosoglou G, Leber A, Schmermund A, Gohlke H, Bruder O, Dill T, Schröder S, Kerber S, Hamm K, Gietzen F, Schneider S, Senges J, Achenbach S. Coronary computed tomography angiography (CCTA) in patients with suspected stable coronary artery disease (CAD): diagnostic impact and clinical consequences in the German Cardiac CT Registry depending on stress test results. Int J Cardiovasc Imaging. 2019 Apr;35(4):741-748.

  2. Assmus B, Leistner DM, Schächinger V, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, Sedding D, Yu J, Corti R, Mathey DG, Barth C, Mayer-Wehrstein C, Burck I, Sueselbeck T, Dill T, Hamm CW, Tonn T, Dimmeler S, Zeiher AM; REPAIR-AMI Study Group. Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival. Eur Heart J. 2014 May 14;35(19):1275-83. doi: 10.1093/eurheartj/ehu062. Epub 2014 Feb 25.
     
  3. Bruder O, Wagner A, Lombardi M, Schwitter J, van Rossum A, Pilz G, Nothnagel D, Steen H, Petersen S, Nagel E, Prasad S, Schumm J, Greulich S, Cagnolo A, Monney P, Deluigi CC, Dill T, Frank H, Sabin G, Schneider S, Mahrholdt H. European Cardiovascular Magnetic Resonance (EuroCMR) registry--multi national results from 57 centers in 15 countries. J Cardiovasc Magn Reson. 2013 Jan 18;15:9. doi: 10.1186/1532-429X-15-9.
     
  4. Schwitter J, Wacker CM, Wilke N, Al-Saadi N, Sauer E, Huettle K, Schönberg SO, Debl K, Strohm O, Ahlstrom H, Dill T, Hoebel N, Simor T; MR-IMPACT investigators. Superior diagnostic performance of perfusion-cardiovascular magnetic resonance versus SPECT to detect coronary artery disease: The secondary endpoints of the multicenter multivendor MR-IMPACT II (Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary Artery Disease Trial). J Cardiovasc Magn Reson. 2012 Sep 2;14:61.
     
  5. Moschetti K, Muzzarelli S, Pinget C, Wagner A, Pilz G, Wasserfallen JB, Schulz-Menger J, Nothnagel D, Dill T, Frank H, Lombardi M, Bruder O, Mahrholdt H, Schwitter J. Cost evaluation of cardiovascular magnetic resonance versus coronary angiography for the diagnostic work-up of coronary artery disease: application of the European Cardiovascular Magnetic Resonance registry data to the German, United Kingdom, Swiss, and United States health care systems. J Cardiovasc Magn Reson. 2012 Jun 14;14:35. doi: 10.1186/1532-429X-14-35.
     
  6. Achenbach S, Barkhausen J, Beer M, Beerbaum P, Dill T, Eichhorn J, Fratz S, Gutberlet M, Hoffmann M, Huber A, Hunold P, Klein C, Krombach G, Kreitner KF, Kühne T, Lotz J, Maintz D, Mahrholdt H, Merkle N, Messroghli D, Miller S, Paetsch I, Radke P, Steen H, Thiele H, Sarikouch S, Fischbach R. [Consensus recommendations of the German Radiology Society (DRG), the German Cardiac Society (DGK) and the German Society for Pediatric Cardiology (DGPK) on the use of cardiac imaging with computed tomography and magnetic resonance imaging]. Rofo. 2012 Apr;184(4):345-68. doi: 10.1055/s-0031-1299400. Epub 2012 Mar 17. German. Erratum in: Rofo. 2012 Apr;184(4):E1. Marholdt, H [corrected to Mahrholdt, H].
     
  7. Schwitter J, Wacker CM, Wilke N, Al-Saadi N, Sauer E, Huettle K, Schönberg SO, Luchner A, Strohm O, Ahlstrom H, Dill T, Hoebel N, Simor T; MR-IMPACT Investigators. MR-IMPACT II: Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary artery disease Trial: perfusion-cardiac magnetic resonance vs. single-photon emission computed tomography for the detection of coronary artery disease: a comparative multicentre, multivendor trial. Eur Heart J. 2013 Mar;34(10):775-81. doi: 10.1093/eurheartj/ehs022. Epub 2012 Mar 4.
     
  8. Zeymer U, Arntz HR, Mark B, Fichtlscherer S, Werner G, Schöller R, Zahn R, Diller F, Darius H, Dill T, Huber K. Efficacy and safety of a high loading dose of clopidogrel administered prehospitally to improve primary percutaneous coronary intervention in acute myocardial infarction: the randomized CIPAMI trial. Clin Res Cardiol. 2012 Apr;101(4):305-12. doi: 10.1007/s00392-011-0393-1. Epub 2011 Dec 21.
     
  9. Bruder O, Schneider S, Nothnagel D, Pilz G, Lombardi M, Sinha A, Wagner A, Dill T, Frank H, van Rossum A, Schwitter J, Nagel E, Senges J, Sabin G, Sechtem U, Mahrholdt H. Acute adverse reactions to gadolinium-based contrast agents in CMR: multicenter experience with 17,767 patients from the EuroCMR Registry. JACC Cardiovasc Imaging. 2011 Nov;4(11):1171-6. doi: 10.1016/j.jcmg.2011.06.019.
     
  10. Hermanides RS, van Houwelingen G, Ottervanger JP, de Boer MJ, Dill T, Hamm C, Stella PR, Boersma E, ten Berg JM, van 't Hof AW; On-TIME 2 trial investigators. The impact of age on effects of pre-hospital initiation of high bolus dose of tirofiban before primary angioplasty for ST-elevation myocardial infarction. Cardiovasc Drugs Ther. 2011 Aug;25(4):323-30. doi: 10.1007/s10557-011-6314-8.
     
  11. Rolf A, Assmus B, Schächinger V, Rixe J, Möllmann S, Möllmann H, Dimmeler S, Zeiher AM, Hamm CW, Dill T. Maladaptive hypertrophy after acute myocardial infarction positive effect of bone marrow-derived stem cell therapy on regional remodeling measured by cardiac MRI. Clin Res Cardiol. 2011 Nov;100(11):983-92. doi: 10.1007/s00392-011-0330-3. Epub 2011 Jun 17.
     
  12. Hermanides RS, Ottervanger JP, Dambrink JH, Dill T, van Houwelingen G, Ten Berg JM, Kolkman E, Hamm C, van 't Hof AW. Risk of bleeding after prehospital administration of high dose tirofiban for ST elevation myocardial infarction. Int J Cardiol. 2012 May 17;157(1):86-90. doi: 10.1016/j.ijcard.2010.12.015. Epub 2010 Dec 30.
     
  13. Heestermans T, Suryapranata H, ten Berg JM, Mosterd A, Gosselink AT, Kochman W, Dill T, van Houwelingen G, Kolkman E, van Werkum JW, Zijlstra F, Hamm C, van 't Hof AW. Facilitated reperfusion with prehospital glycoprotein IIb/IIIa inhibition: predictors of complete ST-segment resolution before primary percutaneous coronary intervention in the On-TIME 2 trial: correlates of reperfusion before primary PCI. J Electrocardiol. 2011 Jan-Feb;44(1):42-8. doi: 10.1016/j.jelectrocard.2010.09.010.
     
  14. Heestermans T, van 't Hof AW, ten Berg JM, van Werkum JW, Boersma E, Mosterd A, Stella PR, van Zoelen AB, Gosselink AT, Kochman W, Dill T, Koopmans PC, van Houwelingen G, Zijlstra F, Hamm C. The golden hour of prehospital reperfusion with triple antiplatelet therapy: a sub-analysis from the Ongoing Tirofiban in Myocardial Evaluation 2 (On-TIME 2) trial early initiation of triple antiplatelet therapy. Am Heart J. 2010 Dec;160(6):1079-84. doi: 10.1016/j.ahj.2010.08.039.
     
  15. Mahabadi AA, Achenbach S, Burgstahler C, Dill T, Fischbach R, Knez A, Moshage W, Richartz BM, Ropers D, Schröder S, Silber S, Möhlenkamp S; Working group "Cardiac CT" of the German Cardiac Society. Safety, efficacy, and indications of beta-adrenergic receptor blockade to reduce heart rate prior to coronary CT angiography. Radiology. 2010 Dec;257(3):614-23. doi: 10.1148/radiol.10100140. Review.
     
  16. Hermanides RS, Heestermans AA, Ten Berg JM, Gosselink AT, Ottervanger JP, van Houwelingen KG, Kolkman JJ, Stella PR, Dill T, Hamm C, van 't Hof AW. High-dose tirofiban pretreatment reduces the need for bail-out study medication in patients with ST-segment elevation myocardial infarction: results of a subgroup analysis of the On-TIME 2 trial. Heart. 2011 Jan;97(2):106-11. doi: 10.1136/hrt.2010.194951. Epub 2010 Oct 20.
     
  17. Smit JJ, van Werkum JW, ten Berg J, Slingerland R, Ottervanger JP, Heestermans T, Dill T, Hamm C, van 't Hof AW; Ongoing Tirofiban in Myocardial Infarction Evaluation (On-TIME) trial investigators. Prehospital triple antiplatelet therapy in patients with acute ST elevation myocardial infarction leads to better platelet aggregation inhibition and clinical outcome than dual antiplatelet therapy. Heart. 2010 Nov;96(22):1815-20. doi: 10.1136/hrt.2010.201889. Epub 2010 Oct 3.
     
  18. Timmer JR, ten Berg J, Heestermans AA, Dill T, van Werkum JW, Dambrink JH, Suryapranata H, Ottervanger JP, Hamm C, van 't Hof AW; Ongoing Tirofiban In Myocardial Infarction Evaluation (On - Time) 2 study group. Pre-hospital administration of tirofiban in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: a sub-analysis of the On-Time 2 trial. EuroIntervention. 2010 Aug;6(3):336-42. doi: 10.4244/EIJV6I3A56.
     
  19. Neumann T, Kuniss M, Conradi G, Janin S, Berkowitsch A, Wojcik M, Rixe J, Erkapic D, Zaltsberg S, Rolf A, Bachmann G, Dill T, Hamm CW, Pitschner HF. MEDAFI-Trial (Micro-embolization during ablation of atrial fibrillation): comparison of pulmonary vein isolation using cryoballoon technique vs. radiofrequency energy. Europace. 2011 Jan;13(1):37-44. doi: 10.1093/europace/euq303. Epub 2010 Sep 8.
     
  20. ten Berg JM, van 't Hof AW, Dill T, Heestermans T, van Werkum JW, Mosterd A, van Houwelingen G, Koopmans PC, Stella PR, Boersma E, Hamm C; On-TIME 2 Study Group. Effect of early, pre-hospital initiation of high bolus dose tirofiban in patients with ST-segment elevation myocardial infarction on short- and long-term clinical outcome. J Am Coll Cardiol. 2010 Jun 1;55(22):2446-55. doi: 10.1016/j.jacc.2009.11.091.
     
  21. Patel MR, Worthley SG, Stebbins A, Dill T, Rademakers FE, Valeti US, Barsness GW, Van de Werf F, Hamm CW, Armstrong PW, Granger CB, Kim RJ. Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial. JACC Cardiovasc Imaging. 2010 Jan;3(1):52-60. doi: 10.1016/j.jcmg.2009.09.014. Epub 2010 Jan 12. Erratum in: JACC Cardiovasc Imaging. 2010 Jul;3(7):796. Velleti, Uma S [corrected to Valeti, Uma S].
     
  22. Assmus B, Rolf A, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, Tillmanns H, Yu J, Corti R, Mathey DG, Hamm CW, Süselbeck T, Tonn T, Dimmeler S, Dill T, Zeiher AM, Schächinger V; REPAIR-AMI Investigators. Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction. Circ Heart Fail. 2010 Jan;3(1):89-96. doi: 10.1161/CIRCHEARTFAILURE.108.843243. Epub 2009 Dec 8.
     
  23. Wagner A, Bruder O, Schneider S, Nothnagel D, Buser P, Pons-Lado G, Dill T, Hombach V, Lombardi M, van Rossum AC, Schwitter J, Senges J, Sabin GV, Sechtem U, Mahrholdt H, Nagel E. Current variables, definitions and endpoints of the European cardiovascular magnetic resonance registry. J Cardiovasc Magn Reson. 2009 Nov 5;11:43. doi: 10.1186/1532-429X-11-43.
     
  24. Bruder O, Schneider S, Nothnagel D, Dill T, Hombach V, Schulz-Menger J, Nagel E, Lombardi M, van Rossum AC, Wagner A, Schwitter J, Senges J, Sabin GV, Sechtem U, Mahrholdt H. EuroCMR (European Cardiovascular Magnetic Resonance) registry: results of the German pilot phase. J Am Coll Cardiol. 2009 Oct 6;54(15):1457-66. doi: 10.1016/j.jacc.2009.07.003. Epub 2009 Aug 13.
     
  25. Heestermans AA, Van Werkum JW, Hamm C, Dill T, Gosselink AT, De Boer MJ, Van Houwelingen G, Hoorntje JC, Koopmans PC, Ten Berg JM, Van 't Hof AW. Marked reduction of early stent thrombosis with pre-hospital initiation of high-dose Tirofiban in ST-segment elevation myocardial infarction. J Thromb Haemost. 2009 Oct;7(10):1612-8. doi: 10.1111/j.1538-7836.2009.03573.x. Epub 2009 Aug 11.
     
  26. Rixe J, Conradi G, Rolf A, Schmermund A, Magedanz A, Erkapic D, Deetjen A, Hamm CW, Dill T. Radiation dose exposure of computed tomography coronary angiography: comparison of dual-source, 16-slice and 64-slice CT. Heart. 2009 Aug;95(16):1337-42. doi: 10.1136/hrt.2008.161018. Epub 2009 May 28.
     
  27. Rolf A, Nef HM, Möllmann H, Troidl C, Voss S, Conradi G, Rixe J, Steiger H, Beiring K, Hamm CW, Dill T. Immunohistological basis of the late gadolinium enhancement phenomenon in tako-tsubo cardiomyopathy. Eur Heart J. 2009 Jul;30(13):1635-42. doi: 10.1093/eurheartj/ehp140. Epub 2009 Apr 23.
     
  28. Rolf A, Dill T. Magnetic Resonance Assessment of Stem Cells. Current Cardiovascular Imaging Reports 2009;April.
     
  29. Neumann T, Kuniss M, Conradi G, Sperzel J, Berkowitsch A, Zaltsberg S, Wojcik M, Erkapic D, Dill T, Hamm CW, Pitschner HF. Pulmonary vein stenting for the treatment of acquired severe pulmonary vein stenosis after pulmonary vein isolation: clinical implications after long-term follow-up of 4 years. J Cardiovasc Electrophysiol. 2009 Mar;20(3):251-7. doi: 10.1111/j.1540-8167.2008.01316.x.
     
  30. Dill T, Schächinger V, Rolf A, Möllmann S, Thiele H, Tillmanns H, Assmus B, Dimmeler S, Zeiher AM, Hamm C. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy. Am Heart J. 2009 Mar;157(3):541-7. doi: 10.1016/j.ahj.2008.11.011. Epub 2009 Jan 31.
     
  31. Rixe J, Rolf A, Conradi G, Moellmann H, Nef H, Neumann T, Steiger H, Hamm CW, Dill T. Detection of relevant coronary artery disease using dual-source computed tomography in a high probability patient series: comparison with invasive angiography. Circ J. 2009 Feb;73(2):316-22. Epub 2008 Dec 27.
     
  32. Erkapic D, Rixe J, Strunk J, Hamm CW, Dill T. Acute aortitis with spinal artery aneurysms detected by contrast enhanced magnetic resonance imaging. Clin Res Cardiol. 2009 Jan;98(1):59-61. doi: 10.1007/s00392-008-0714-1. Epub 2008 Aug 30. No abstract available.
     
  33. Van't Hof AW, Ten Berg J, Heestermans T, Dill T, Funck RC, van Werkum W, Dambrink JH, Suryapranata H, van Houwelingen G, Ottervanger JP, Stella P, Giannitsis E, Hamm C; Ongoing Tirofiban In Myocardial infarction Evaluation (On-TIME) 2 study group. Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial. Lancet. 2008 Aug 16;372(9638):537-46. doi: 10.1016/S0140-6736(08)61235-0.
     
  34. Weber C, Weber M, Ekinci O, Neumann T, Deetjen A, Rolf A, Adam G, Hamm CW, Dill T. Atrial septal defects type II: noninvasive evaluation of patients before implantation of an Amplatzer Septal Occluder and on follow-up by magnetic resonance imaging compared with TEE and invasive measurement. Eur Radiol. 2008 Nov;18(11):2406-13. doi: 10.1007/s00330-008-1033-7. Epub 2008 Jun 21.
     
  35. Dill T. Contraindications to magnetic resonance imaging: non-invasive imaging. Heart. 2008 Jul;94(7):943-8. doi: 10.1136/hrt.2007.125039. Review. No abstract available.
     
  36. Möllmann H, Weber M, Elsässer A, Nef H, Dill T, Rixe J, Schmitt J, Sperzel J, Hamm CW. NT-ProBNP predicts rhythm stability after cardioversion of lone atrial fibrillation. Circ J. 2008 Jun;72(6):921-5.
     
  37. Rixe J, Rolf A, Conradi G, Elsaesser A, Moellmann H, Nef HM, Bachmann G, Hamm CW, Dill T. Image quality on dual-source computed-tomographic coronary angiography. Eur Radiol. 2008 Sep;18(9):1857-62. doi: 10.1007/s00330-008-0947-4. Epub 2008 Apr 17.
     
  38. Nef HM, Möllmann H, Hilpert P, Krause N, Troidl C, Weber M, Rolf A, Dill T, Hamm C, Elsässer A. Apical regional wall motion abnormalities reminiscent to Tako-Tsubo cardiomyopathy following consumption of psychoactive fungi. Int J Cardiol. 2009 May 1;134(1):e39-41. doi: 10.1016/j.ijcard.2007.12.064. Epub 2008 Apr 2.
     
  39. Möllmann H, Nef H, Willmer M, Joseph A, Weber M, Rixe J, Rolf A, Dill T, Hamm C, Elsässer A. Percutaneous closure of a saphenous vein graft aneurysm being at risk for rupture. Clin Res Cardiol. 2008 Mar;97(3):187-90. doi: 10.1007/s00392-007-0627-4. Epub 2008 Feb 22. No abstract available.
     
  40. Schwitter J, Wacker CM, van Rossum AC, Lombardi M, Al-Saadi N, Ahlstrom H, Dill T, Larsson HB, Flamm SD, Marquardt M, Johansson L. MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J. 2008 Feb;29(4):480-9. doi: 10.1093/eurheartj/ehm617. Epub 2008 Jan 21.
     
  41. Steiger H, Dill T. Cardiomyopathy complicated by a thrombo-embolic event and ventricular tachycardia. Der Kardiologe 2008;2:121-123.
     
  42. Rolf A, Dill T. Koronaranomalien – atypischer Abgang aus dem gegenüberliegendne Sinus valsalvae mit interarteriellem Verlauf (ACAOS). Der Kardiologe 2008;6:506-512.
     
  43. Nef HM, Möllmann H, Troidl C, Kostin S, Böttger T, Voss S, Hilpert P, Krause N, Weber M, Rolf A, Dill T, Schaper J, Hamm CW, Elsässer A. Expression profiling of cardiac genes in Tako-Tsubo cardiomyopathy: insight into a new cardiac entity. J Mol Cell Cardiol. 2008 Feb;44(2):395-404. Epub 2007 Dec 3.
     
  44. Nef HM, Möllmann H, Hilpert P, Masseli F, Troidl C, Rolf A, Dill T, Skwara W, Weber M, Hamm C, Elsässer A. Severe mitral regurgitation in Tako-Tsubo cardiomyopathy. Int J Cardiol. 2009 Feb 20;132(2):e77-9. Epub 2007 Nov 28.
     
  45. Nef HM, Möllmann H, Hilpert P, Masseli F, Kostin S, Troidl C, Rolf A, Dill T, Weber M, Hamm C, Elsässer A. Sympathoadrenergic overstimulation in Tako-Tsubo cardiomyopathy triggered by physical and emotional stress. Int J Cardiol. 2008 Nov 12;130(2):266-8. Epub 2007 Aug 17.
     
  46. Dill T, Deetjen A, Ekinci O, Möllmann S, Conradi G, Kluge A, Weber C, Weber M, Nef H, Hamm CW. Radiation dose exposure in multislice computed tomography of the coronaries in comparison with conventional coronary angiography. Int J Cardiol. 2008 Mar 14;124(3):307-11. Epub 2007 Apr 3.
     
  47. Nef HM, Möllmann H, Kostin S, Troidl C, Voss S, Weber M, Dill T, Rolf A, Brandt R, Hamm CW, Elsässer A. Tako-Tsubo cardiomyopathy: intraindividual structural analysis in the acute phase and after functional recovery. Eur Heart J. 2007 Oct;28(20):2456-64. Epub 2007 Mar 29.
     
  48. Dill T, Hamm CW. Stellenwert der MRT und der Mehrschicht Computer-Tomographie in der Diagnostik bei akutem Thoraxschmerz. Kardiologie up2date 2007; 3. Jahrgang: 251-260.
     
  49. Deetjen A, Möllmann S, Conradi G, Rolf A, Schmermund A, Hamm CW, Dill T. Use of automatic exposure control in multislice computed tomography of the coronaries: comparison of 16-slice and 64-slice scanner data with conventional coronary angiography. Heart. 2007 Sep;93(9):1040-3. Epub 2007 Mar 29.
     
  50. Deetjen AG, Conradi G, Möllmann S, Ekinci O, Weber M, Nef H, Möllmann H, Hamm CW, Dill T. Diagnostic value of the 16-detector row multislice spiral computed tomography for the detection of coronary artery stenosis in comparison to invasive coronary angiography. Clin Cardiol. 2007 Mar;30(3):118-23.
     
  51. Möllmann H, Nef HM, Weber M, Rau M, Dill T, Hamm CW, Elsässer A. Recurrent angina after complete coronary revascularization. Clin Res Cardiol. 2007 May;96(5):295-8. Epub 2007 Feb 26. No abstract available.
     
  52. Conradi G, Deetjen A, Mollmann S, Hamm CW, Dill T. Symptomatic atrial fibrillation as the first symptom of a giant left atrial appendage aneurysm. Clin Res Cardiol. 2006 Nov;95(11):614-6.
     
  53. Kluge A, Gerriets T, Stolz E, Dill T, Mueller KD, Mueller C, Bachmann G. Pulmonary perfusion in acute pulmonary embolism: agreement of MRI and SPECT for lobar, segmental and subsegmental perfusion defects. Acta Radiol. 2006 Nov;47(9):933-40.
     
  54. Maksimović R, Dill T, Seferović PM, Ristić AD, Alter P, Simeunović DS, Marković Z, Bachmann GF, Maisch B. Magnetic resonance imaging in pericardial diseases. Indications and diagnostic value. Herz. 2006 Oct;31(7):708-14. Review. No abstract available.
     
  55. Nef HM, Mollmann H, Vogt A, Weber M, Deetjen A, Dill T, Brandt R, Hamm CW, Elsässer A. Multiple episodes of a transient global left ventricular dysfunction reminiscent to apical ballooning. Cardiology. 2007;108(1):1-3. Epub 2006 Sep 5.
     
  56. Conradi G, Deetjen A, Möllmann S, Hamm CW, Dill T. Symptomatic atrial fibrillation as the first symptom of a giant left atrial appendage aneurysm. Clin Res Cardiol. 2006 Nov;95(11):614-6. Epub 2006 Aug 16. No abstract available.
     
  57. Deetjen A, Conradi G, Möllmann S, Kluge A, Hamm CW, Dill T. Cardiac metastasis of a renal cell adenocarcinoma investigated by cardiac magnetic resonance imaging. Clin Res Cardiol. 2006 Sep;95(9):492-5. Epub 2006 Jul 14. No abstract available.
     
  58. Neumann T, Erdogan A, Dill T, Greiss H, Berkowitsch A, Sperzel J, Kuniss M, Kurzidim K, Hamm CW, Pitschner HF. Asymptomatic recurrences of atrial fibrillation after pulmonary vein isolation. Europace. 2006 Jul;8(7):495-8.
     
  59. Maksimović R, Dill T, Ristić AD, Seferović PM. Imaging in percutaneous ablation for atrial fibrillation. Eur Radiol. 2006 Nov;16(11):2491-504. Epub 2006 May 20. Review.
     
  60. Deetjen AG, Conradi G, Mollmann S, Rad A, Hamm CW, Dill T. Value of gadolinium-enhanced magnetic resonance imaging in patients with Tako-Tsubo-like left ventricular dysfunction. J Cardiovasc Magn Reson. 2006;8(2):367-72.
     
  61. Deetjen AG, Conradi G, Möllmann S, Hamm CW, Dill T. Cardiac angiosarcoma diagnosed and characterized by cardiac magnetic resonance imaging. Cardiol Rev. 2006 Mar-Apr;14(2):101-3.
     
  62. Rieth A, Dill T, Deetjen A, Djuric D, Mitrovic V. Effects of homocysteine-lowering therapy on endothelial function, carotid wall thickness, and myocardial perfusion. ACTA FAC MED NAISS 2006;23(4):179-184.
     
  63. Brandt RR, Arnold R, Bohle RM, Dill T, Hamm CW. Cardiac angiosarcoma: case report and review of the literature. Z Kardiol. 2005 Dec;94(12):824-8. Review.
     
  64. Nef HM, Möllmann H, Möllmann S, Dill T, Hamm CW, Elsässer A. Primary stenting of the left main coronary artery with anomalous origin from the right sinus of valsalva. Int J Cardiol. 2007 Jan 2;114(1):137-8. Epub 2005 Dec 27.
     
  65. Neumann T, Sperzel J, Dill T, Kluge A, Erdogan A, Greis H, Hansel J, Berkowitsch A, Kurzidim K, Kuniss M, Hamm CW, Pitschner HF. Percutaneous pulmonary vein stenting for the treatment of severe stenosis after pulmonary vein isolation. J Cardiovasc Electrophysiol. 2005 Nov;16(11):1180-8.
     
  66. Kluge A, Gerriets T, Müller C, Ekinci O, Neumann T, Dill T, Bachmann G. [Thoracic real-time MRI: experience from 2200 examinations in acute and ill-defined thoracic diseases]. Rofo. 2005 Nov;177(11):1513-21. German.
     
  67. Maksimović R, Ekinci O, Reiner C, Bachmann GF, Seferović PM, Ristić AD, Hamm CW, Pitschner HF, Dill T. The value of magnetic resonance imaging for the diagnosis of arrhythmogenic right ventricular cardiomyopathy. Eur Radiol. 2006 Mar;16(3):560-8. Epub 2005 Oct 25.
     
  68. Weber M, Dill T, Deetjen A, Neumann T, Ekinci O, Hansel J, Elsaesser A, Mitrovic V, Hamm C. Left ventricular adaptation after atrial septal defect closure assessed by increased concentrations of N-terminal pro-brain natriuretic peptide and cardiac magnetic resonance imaging in adult patients. Heart. 2006 May;92(5):671-5. Epub 2005 Oct 10.
     
  69. Deetjen A, Möllmann S, Dill T, Hamm CW. Left atrial myxoma diagnosed and characterized by cardiac magnetic resonance imaging. Z Kardiol. 2005 Oct;94(10):695-8.
     
  70. Elsässer A, Möllmann H, Nef H, Dill T, Brandt R, Skwara W, Hennig T, Rau M, Hamm C. Transcatheter closure of a ruptured ventricular septum after myocardial infarction using a venous approach. Z Kardiol. 2005 Oct;94(10):684-9.
     
  71. Dill T, Ekinci O, Hansel J, Kluge A, Breidenbach C, Hamm CW. Delayed contrast-enhanced magnetic resonance imaging for the detection of autoimmune myocarditis and long-term follow-up. J Cardiovasc Magn Reson. 2005;7(2):521-3.
     
  72. Berkowitsch A, Neumann T, Ekinci O, Greiss H, Dill T, Kurzidim K, Kuniss M, Schneider HJ, Pitschner HF. A decrease in pulmonary vein diameter after radiofrequency ablation predicts the development of severe stenosis. Pacing Clin Electrophysiol. 2005 Jan;28 Suppl 1:S83-5.
     
  73. Dill T, Breidenbach C, John A, Brandt RR, Ekinci O, Szalay Z, Bauer EP, Ricken W, Bachmann G, Hamm CW. Pre- and postoperative assessment of left ventricular function by magnetic resonance imaging and 2-D-echocardiography in patients undergoing left ventricular aneurysmectomy. Thorac Cardiovasc Surg. 2004 Oct;52(5):274-9.
     
  74. Weber M, Dill T, Arnold R, Rau M, Ekinci O, Müller KD, Berkovitsch A, Mitrovic V, Hamm C. N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris. Am Heart J. 2004 Oct;148(4):612-20.
     
  75. Kluge A, Dill T, Ekinci O, Hansel J, Hamm C, Pitschner HF, Bachmann G. Decreased pulmonary perfusion in pulmonary vein stenosis after radiofrequency ablation: assessment with dynamic magnetic resonance perfusion imaging. Chest. 2004 Aug;126(2):428-37.
     
  76. John A, Dill T. Magnetic resonance to assess the aortic valve area in aortic stenosis: how does it compare to current diagnostic standards? J Am Coll Cardiol. 2004 Jun 2; 43(11):2148; author reply 2148–9.
     
  77. Szalay ZA, Civelek A, Dill T, Klövekorn WP, Kilb I, Bauer EP. Long-term follow-up after the mini-maze procedure. Ann Thorac Surg. 2004 Apr;77(4):1277-81.
     
  78. Weber M, Neumann T, Rau M, Brandt R, Dill T, Maikowski C, Mitrovic V, Hamm C. [Cardiopulmonary exercise capacity increases after interventional ASD-closure]. Z Kardiol. 2004 Mar;93(3):209-15. German.
     
  79. John AS, Dill T, Brandt RR, Rau M, Ricken W, Bachmann G, Hamm CW. Magnetic resonance to assess the aortic valve area in aortic stenosis: how does it compare to current diagnostic standards? J Am Coll Cardiol. 2003 Aug 6;42(3):519-26.
     
  80. Dix WR, Kupper W, Dill T, Hamm CW, Job H, Lohmann M, Reime B, Ventura R. Comparison of intravenous coronary angiography using synchrotron radiation with selective coronary angiography. J Synchrotron Radiat. 2003 May 1;10(Pt 3):219-27. Epub 2003 Apr 25.
     
  81. Dill T, Neumann T, Ekinci O, Breidenbach C, John A, Erdogan A, Bachmann G, Hamm CW, Pitschner HF. Pulmonary vein diameter reduction after radiofrequency catheter ablation for paroxysmal atrial fibrillation evaluated by contrast-enhanced three-dimensional magnetic resonance imaging. Circulation. 2003 Feb 18;107(6):845-50.
     
  82. Weber C, Dill T, Mommert I, Hofmann T, Adam G. [The role of MRI for the evaluation of atrial septal defects before and after percutaneous occlusion with the amplatzer septal occluder(R)]. Rofo. 2002 Nov;174(11):1387-94. German.
     
  83. Dill T, Vom Dahl J. [Role of atherectomy devices in interventional cardiology]. Herz. 2002 Sep;27(6):502-7. Review. German.
     
  84. Weber C, Steiner P, Sinkus R, Dill T, Börnert P, Adam G. Correlation of 3D MR coronary angiography with selective coronary angiography: feasibility of the motion-adapted gating technique. Eur Radiol. 2002 Apr;12(4):718-26. Epub 2001 Dec 15.
     
  85. Dietz U, Rupprecht HJ, Ekinci O, Dill T, Erbel R, Kuck KH, Abdollahnia R, Rippin G, Meyer J, Hamm C. Angiographic analysis of immediate and long-term results of PTCR vs. PTCA in complex lesions (COBRA study). Catheter Cardiovasc Interv. 2001 Jul;53(3):359-67.
     
  86. Ventura R, Dill T, Dix WR, Lohmann M, Job H, Kupper W, Fattori R, Nienaber CA, Hamm CW, Meinertz T. Intravenous coronary angiography using synchrotron radiation: technical description and preliminary results. Ital Heart J. 2001 Apr;2(4):306-11.
     
  87. Dill T, Dietz U, Hamm CW, Küchler R, Rupprecht HJ, Haude M, Cyran J, Ozbek C, Kuck KH, Berger J, Erbel R. A randomized comparison of balloon angioplasty versus rotational atherectomy in complex coronary lesions (COBRA study). Eur Heart J. 2000 Nov;21(21):1759-66.
     
  88. Dill T, Job H, Dix WR, Ventura R, Kupper W, Hamm CW, Meinertz T. [Intravenous coronary angiography with synchrotron radiation]. Z Kardiol. 2000;89 Suppl 1:27-33. German.
     
  89. Jung M, Dill T, Dix WR, Hamm CW, Kupper W, Lohmann M, Reime B,  Ventura R. Rapid Computer-Assisted Diagnostics in Intravenous Coronary Angiography. Computers in Cardiology 1999 (IEEE); 26:359–362.
     
  90. Dill T, Dix WR, Hamm CW, Jung M, Kupper W, Lohmann M, Reime B,  Ventura R. Intravenous Coronary Angiography: Experience in 276 Patients. Synchrotron Radiation News 1998; Vol. 11, No. 2:12–20.
     
  91. Dill T, Dix WR, Hamm CW. Intravenous coronary angiography with synchrotron radiation. European Journal of  Physics 1998; 19:499–511.
     
  92. Dill T, Hamm CW. [Rotational atherectomy: technique, indications, results]. Herz. 1997 Dec;22(6):291-8. Review. German.
     
  93. Erbel R, Dill T, Dietz U et al. on behalf of the COBRA-Study group: A randomized study of high speed rotational atherectomy and percutaneous transluminal coronary angioplasty in patients with complex coronary artery stenoses (COBRA study). J Interv Cardiol 1997; 10:271–275.

 

Buchbeiträge

  1. Dill T, Ventura R, Dix WR, Dünger O, Jung M, Lohmann M, Reime B, Kupper W, Hamm CW. Intravenous Coronary Angiography with Dichromography using Synchrotron Radiation. Ando M, Uyama C (Eds.): Medical Applications of Synchrotron Radiation. Springer Verlag Tokyo 1998.
  2. Dill T, Buschmann I. Komponenten des EKG und Leitwege zur EKG-Befundung und Therapie, in Hamm CW, Willems S: Checkliste Elektrokardiographie. Thieme Verlag, Stuttgart, 1998.
  3. Dill T, Buschmann I. Komponenten des EKG und Leitwege zur EKG-Befundung und Therapie, in Hamm CW, Willems S: Checkliste Elektrokardiographie. Thieme Verlag, Stuttgart, 2. Auflage, 2001.
  4. Dill T, Brandt RR, Hamm C. Koronare Herzkrankheit. Alexander und Konstantin Bob (Herausgeber). Duale Reihe Innere Medizin. Thieme Verlag, Stuttgart, Neuauflage 2008.
  5. Dill T, Hamm C. Akutes Koronarsyndrom. Alexander und Konstantin Bob (Herausgeber). Duale Reihe Innere Medizin. Thieme Verlag, Stuttgart, Neuauflage 2008.
  6. Köster R, Dill T, Hamm C. Angeborene Herz- und Gefäßfehlbildungen. Alexander und Konstantin Bob (Herausgeber). Duale Reihe Innere Medizin. Thieme Verlag, Stuttgart, Neuauflage 2008.
  7. Brandt RR, Dill T, Hamm C. Erworbene Herzklappenfehler. Alexander und Konstantin Bob (Herausgeber). Duale Reihe Innere Medizin. Thieme Verlag, Stuttgart, Neuauflage 2008.
  8.  Dill T, Hamm C. Innere Medizin/Kardiologie-Angiologie. Pschyrembel Handbuch Therapie. Walter deGruyter Verlag, Berlin; Neuauflage 2009.

 

Sekretariat

Sabine Kreutz

Tel.: 0211 2800-1221
sabine.kreutz@sana.de  

Terminvereinbarung Privatambulanz - mehr

Krankenhaus-Hotline:
0211 2800-02

Kardiologie

Leitender Oberarzt

image

Dr. med. Simon Ohm
Leitender Oberarzt Medizinische Klinik
Innere Medizin, Kardiologie, Sportmedizin, Notfallmedizin
Interventionelle Kardiologie
Herzinsuffizienz-Spezialist
Zusatzqualifikation Sportkardiologie Stufe 2

Simon.ohm@sana.de

 

 

Oberarzt

Dr. Peter Schoppe

Dr. med. Peter Schoppe
Oberarzt
Innere Medizin, Kardiologie, Internistische Intensivmedizin
Zertifizierter interventioneller Kardiologie

Peter.schoppe@sana.de

 

Oberarzt

Dr. medic Andrei Rosu
Oberarzt
Innere Medizin, Kardiologie

andrei.rosu@sana.de

Rhythmologie und Elektrophysiologie

Chefarzt

image

Privatdozent Dr. med. Bülent Köktürk

Invasive Elektrophysiologie und Rhythmologie
Klinik für Kardiologie / Klinik für Innere Medizin

buelent.koektuerk@sana.de

 

Sekretariat

Sandra Schorn
Tel.: 0211 2800-1505
Fax: 0211 2800-1452
sandra.schorn@sana.de  oder rhythmologie.benrath@sana.de

Krankenhaus-Hotline:
0211 2800-02

 

Leiter Devicetherapie

image

Dr. med. Markus Siekiera
Oberarzt

Facharzt für Innere Medizin und Kardiologie, Internist
Zusatzbezeichnung Notfallmedizin und internistische Intensivmedizin
Curriculum aktive Rhythmusimplantate der DGK
Proctor CIED-Implantationen (Leadless-, His-/LBB-Pacer, S-ICD)

markus.siekiera@sana.de

Curriculum Vitae Dr. med. Markus Siekiera

Dr. med. Markus Siekiera  wurde in Stettin geboren. Er studierte Medizin  an der Universität Hamburg und Würzburg. Von 2005 bis 2013 war er in der Klinik und Poliklinik für Kardiologie, Pulmologie und Angiologie der Universität Düsseldorf tätig. Das Angebot Oberarzt und später Leitender Oberarzt am Akademischen Lehrkrankenhaus der Heinrich-Heine-Universität Düsseldorf zu werden, nahm er  2013 an und wechselte zum Augusta Krankenhaus Düsseldorf.  Er absolvierte die Prüfungen zum Internisten 2010 und Kardiologen 2014 und promovierte  an der Julius Maximilian Universität Würzburg 2009. Er erwarb die Zusatzbezeichnungen der Notfallmedizin und Internistischen Intensivmedizin, war jahrelang als Notarzt der Stadt Düsseldorf tätig.  Er leitete wissenschaftliche Arbeitsgruppen als anerkannter Prüfarzt und  ist Fellow of the European Society of Cardiology (FESC), sowie Mitglied der Deutschen Gesellschaft für Kardiologie (DGK).  Seit vielen Jahren ist er als Berater und Proctor in CIED (Cardiovasular Implantable Elektronic Devices) bekannt. Nach langjähriger Tätigkeit als Oberarzt und leitender Oberarzt wechselte er 2021 zur Medizinischen Klinik an das Sana Krankenhaus Benrath.

Publikationsverzeichnis Dr. med. Markus Siekiera

  • T. Bettecken, C. Rubie, P. Lichtner, M. Siekiera, T. Meitinger und G. Stöber (2002). Reduced amplification efficiency of KIAA0027/MLC1 alleles: Implications for the molecular diagnosis of megalencephalic leucoencephylopathy with subcortical cysts. Molecular and Cellular Probes 16: 379 – 384.
  • C. Rubie, P. Lichtner, J. Gärtner, M. Siekiera, G. Uziel, B. Kohlmann, A. Kohlschütter, T. Meitinger, G. Stöber und T. Bettecken (2003). Sequence diversity of KIAA0027/MLC1: Are Megalencephalic leucoencephalopathy schizophrenia allelic disorders? Human Mutation 21: 45 – 52.
  • Eickholt C, Siekiera M, Kirmanoglou K, Rodenbeck A, Heussen N, Schauerte P, Lichtenberg A, Balzer J, Rassaf T, Perings S, Kelm M, Shin DI, Meyer C (2012) Improvement of left ventricular function under cardiac resynchronization therapy goes along with a reduced incidence of ventricular arrhythmia. Plos one 7: e48926.
  • Drexel T, Eickholt C, Mühlsteff J, Ritz A, Siekiera M, Kirmanoglou K, Schulze V, Shin DI, Balzer J, Rassaf T, Kelm M, Meyer C. (2013) Vagal heart rate control in patients with atrial fibrillation: impact of tonic activation of peripheral chemosensory function in heart failure. Advances in experimental medicine and biology 755:287-97.
  • Winter J, Siekiera M, Shin DI, Meyer C, Kröpil P, Clahsen H, O'Connor S. Intermuscular technique for implantation of the subcutaneous implantable cardioverter defibrillator: long-term performance and complications. Europace. 2016 Dec 22
  • Ciesielski A, Boczar K, Siekiera M, Gajek J, Slawuta Al. The clinical utility of direct His bundle pacing in patients with heart failure an permanent atrial fibrillation. Advances in clinical and experimental medicine in press 2021

Viszeralmedizin/Spezielle Gastroenterologie

Chefarzt

image

Dr. med. Michael Birkenfeld
Facharzt für Innere Medizin/Gastroenterologie

michael.birkenfeld@sana.de

Kurzbiografie Dr. med. Michael Birkenfeld

Seit 08/2022:
Chefarzt Viszeralmedizin 
Spezielle Gastroenterologie,
Sana Kliniken Düsseldorf, Betriebsstätten Gerresheim und Benrath

10/2021 – 08/2022:
Sektionsleiter Gastroenterologie
Abteilung für Innere Medizin, Sana Klinikum Gerresheim

01/2020 – 10/2022:
Leitender Oberarzt der Gastroenterologie
Abteilung für Innere Medizin, Gastroenterologie, Hämatologie und Onkologie
St. Vinzenz-Krankenhaus Düsseldorf, VKKD

10/2006 – 01/2020:
Oberarzt der Gastroenterologie
Abteilung für Innere Medizin, Gastroenterologie, Hämatologie und Onkologie
St. Vinzenz-Krankenhaus Düsseldorf, VKKD

03/2013:
Erlangung DGVS-Zertifikat Onkologische Gastroenterologie

04/2007:
Erlangung der Zusatzbezeichnung Gastroenterologie Landesärztekammer Nordrhein

04/2005 – 09/2006:
Facharzt
Abteilung für Innere Medizin, Gastroenterologie, Hämatologie und Onkologie
St. Vinzenz-Krankenhaus Düsseldorf, VKKD

04/2005:
Anerkennung als Facharzt Innere Medizin
Landesärztekammer Hessen

05/2001 – 02/2005:
Assistenzarzt
Abteilung für Innere Medizin, Gastroenterologie, Allergologie und Pneumologie
Katharina-Kasper-Kliniken gGmbH, Frankfurt/Main

08/2000 – 04/2001:
Assistenzarzt Innere Medizin und Kardiologie,
Dr. Horst-Schmidt-Kliniken, Wiesbaden

05/1999:
Erlangung der Doktorwürde
Johannes Gutenberg Universität Mainz, Klinikum für Radiologie

 

Düsseldorf, Oktober 2022

Sekretariat

image

Anja Novak
Tel.: 0211 2800-3355
Fax: 0211 2800-947

anja.novak@sana.de

 

Oberärztin

Claudia Uhlenbruck

Claudia Uhlenbruck
Oberarzt
Innere Medizin, Gastroenterologie

Claudia.uhlenbruck@sana.de

Oberarzt

Tuan Vu

Tuan Vu
Oberarzt
Innere Medizin

tuan.vu@sana.de

Onkologie/Hämatologie

Oberarzt

Dr. Frank Meierkord

Dr. med. Frank Meierkord
Oberarzt
Innere Medizin, Hämatologie/Internistische Onkologie und Palliativmedizin
Ansprechpartner Palliativbehandlung

frank.meierkord@sana.de